Biomarkers for Hepatocellular Apoptosis in the Management of Liver Diseases

E-ISSN： 1873-4316|13|11|2221-2227

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.11, 2012-01, pp. : 2221-2227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Expression Patterns and Clinical Significance of microRNAs in Liver Diseases and Hepatocellular Carcinoma

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1262-1272

Bentham Science Publishers

Access to resources Recommend Favorite

Medical Management of Chronic Liver Diseases in Children (Part I): Focus on Curable or Potentially Curable Diseases

By El-Shabrawi Mortada H.F. Kamal Naglaa M.

Pediatric Drugs, Vol. 13, Iss. 6, 2011-12 ,pp. : 357-370

Adis International

Access to resources Recommend Favorite

The Unbiased Search of Biomarkers in Neurodegenerative Diseases

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 5, 2016-04 ,pp. : 471-479

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Redox Biomarkers in Neurodegenerative Diseases

Current Drug Metabolism, Vol. 16, Iss. 1, 2015-01 ,pp. : 46-70

Bentham Science Publishers

Access to resources Recommend Favorite

Liver Transplantation for Hepatocellular Carcinoma: An Update

By Botha Jean F. Langnas Alan N.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 8, 2006-09 ,pp. : 762-767

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite